Multiple sclerosis (MS) is a complex autoimmune disease of the central nervous system with a prominent genetic component. The primary genetic risk factor is the human leukocyte antigen (HLA)-DRB1*1501 allele; however, much of the remaining genetic contribution to MS has not been elucidated. The authors investigated the relation between variation in DNA repair pathway genes and risk of MS. Single-locus association testing, epistatic tests of interactions, logistic regression modeling, and nonparametric Random Forests analyses were performed by using genotypes from 1,343 MS cases and 1,379 healthy controls of European ancestry. A total of 485 single nucleotide polymorphisms within 72 genes related to DNA repair pathways were investigated, including base excision repair, nucleotide excision repair, and double-strand breaks repair. A single nucleotide polymorphism variant within the general transcription factor IIH, polypeptide 4 gene, GTF2H4, on chromosome 6p21.33 was significantly associated with MS (odds ratio ¼ 0.7, P ¼ 3.5 3 10 À5 ) after accounting for multiple testing and was not due to linkage disequilibrium with HLA-DRB1*1501. Although other candidate genes examined here warrant further follow-up studies, collectively, these results derived from a well-powered study do not support a strong role for common variation within DNA repair pathway genes in MS.
Multiple sclerosis (MS) is a chronic inflammatory and demyelinating autoimmune disease of the central nervous system with a substantial genetic component (1) . Susceptibility to MS has been primarily associated with class II human leukocyte antigen (HLA) genes within the major histocompatibility complex on chromosome 6p21, specifically the HLA-DR2 (or HLA-DR15) haplotype (DQ beta 1, *0602 allele (DQB1*0602), DQ beta 1, *0102 allele (DQA1*0102), DR beta 1, *1501 allele (DRB1*1501), DR beta 5, *0101 allele (DRB5*0101)) (1) . Recent haplotype analyses in admixed African Americans have confirmed HLA-DRB1*1501/3 (HLA-DRB1*1501 or 1503) as the primary susceptibility allele (2, 3) .
Identification of all non-major histocompatibility complex genetic risk factors has proven difficult. Recent genomewide association and replication studies have begun to identify and confirm additional genetic risk factors for MS, including interleukin 7 receptor, alpha (IL7RA), interleukin 7 receptor, alpha (IL2RA), C-type lectin domain family 16, member A (CLEC16A), CD58, tumor necrosis factor receptor superfamily member 1A (TNFRSFA1), interferon regulatory factor 8 (IRF8), kinesin family member 21B (KIF21B), and transmembrane protein 39A (TMEM39A), although their effects on risk are modest at best (4) (5) (6) (7) (8) (9) (10) . A substantial component of the genetic susceptibility to MS remains unknown, underscoring a complex polygenic pattern of inheritance contributing to disease susceptibility. Although genomewide association studies are attractive for many reasons, including their ''hypothesis free'' nature, it is clear that experiments using current technology will be limited in their ability to identify the entire genetic contribution for most complex diseases, including MS (11) . Candidate gene studies have historically failed to identify susceptibility loci with conclusive evidence. However, revisiting candidate gene studies with 1) adequately powered data sets, 2) hypotheses supported from prior research, and 3) analytic approaches that can consider variation within biologic pathways and thus variation within several related genes simultaneously remains an important strategy for disease gene identification (12, 13) . Several candidate biologic pathways are thought to contribute to MS susceptibility. The current study focused on genetic variation within pathways related to DNA repair.
A potential role for DNA repair genes in MS is suggested by a significant increase in total DNA (nuclear DNA and mitochondrial DNA) damage in active MS lesions compared with normal-appearing white matter of MS brains (14) . Further investigation suggests that damage predominantly affects mitochondrial DNA (15) . Gene expression studies have shown that multiple genes involved in DNA repair are differentially expressed in MS lymphocytes and lesions when compared with control tissues, including genes involved in base excision repair (i.e., poly (ADP-ribose) polymerase 1 (PARP1), 8-oxoguanine DNA glycosylase (OGG1), uracil-DNA glycosylase (UNG)), nucleotide excision repair (i.e., replication protein A1 (RPA1), excision repair crosscomplementing rodent repair deficiency, complementation group 5 (ERCC5)), nonhomologous end-joining repair (i.e., protein kinase, DNA-activated, catalytic polypeptide (PRKDC)), and several other DNA repair mechanisms (i.e., direct reversal and mismatch repair) (16) (17) (18) . In addition, strong evidence supports involvement of genotoxic agents in MS, including tobacco smoke and nitric oxide (19) (20) (21) . These lines of evidence strongly suggest a plausible biologic role for DNA repair in the etiology of MS. We investigated a total of 72 genes related to (or within) 4 distinct DNA repair pathways: base excision repair, nucleotide excision repair, and repair of double-strand breaks (homologous recombination and nonhomologous end joining).
MATERIALS AND METHODS

Study population
Through the collaborative efforts of the International Multiple Sclerosis Genetics Consortium, the data set comprised 2,961 participants (1,488 MS cases and 1,512 controls) recruited from 3 clinical centers (University of California, San Francisco; Harvard/MIT Board Institute, Cambridge, Massachusetts; and Cambridge University, Cambridge, Massachusetts) (10) . All MS cases met wellestablished disease criteria (22, 23) . Unrelated controls were obtained from these same US sites and from the British 1958 Birth Cohort Study. These controls were selected to provide nearly equivalent gender and age distributions (10) . Informed consent was obtained from all study participants, and approvals from local institutional review boards were secured at each recruitment site prior to enrollment. All participants self-reported as non-Hispanic white.
Genotyping and quality control DNA repair genes were identified from a detailed gene inventory (Web Table 1 Additional genic SNPs, which may introduce a deleterious amino acid substitution affecting protein function as determined by in silico analysis, were also selected for genotyping. Deleterious SNPs were identified by using the Sorting Intolerant From Tolerant program, which predicts how protein function may be affected by amino acid substitution by comparing sequence homology and physical properties of amino acids (27) . All nonsynonymous SNPs (retrieved from the Single Nucleotide Polymorphism database (dbSNP), July 2007 (http://www.ncbi.nlm.nih.gov/projects/SNP/)) for genes of interest, identified as having a potential damaging effect on protein function, were selected for genotyping, in addition to tagging SNPs.
All individuals were genotyped for 564 SNPs, as a subset of 48,767 custom SNPs, by using the Illumina Infinium 60K BeadChip assay (28) . A rigorous quality control protocol was utilized. Briefly, the Whole-genome Association Study Pipeline assessed sample and SNP genotyping efficiency (<95%), allele frequencies, gender errors, and HardyWeinberg equilibrium (<0.0001) (4). This process was performed recursively. Samples were excluded if the probability of Caucasian European descent was <0.90. Additional quality control processes were performed, including assessment of population outliers, as previously described (10) . The final quality control analysis yielded 2,722 individuals and 46,874 SNPs, 501 of which were relevant to this analysis. We excluded 16 SNP variants with a minor allele frequency of <0.01. Therefore, a total of 485 SNPs (including 25 nonsynonymous variants) within 72 genes related to DNA repair pathways (22 base excision repair genes, 26 nucleotide excision repair genes, 15 homologous recombination genes, and 9 nonhomologous end-joining genes) were investigated in 1,343 MS cases and 1,379 healthy controls of European ancestry (for a complete gene list, refer to Web Table 1 ). The rs3135388 (A/G) SNP was used to determine the presence of the HLA-DRB1*1501 allele, as previously described (29) .
Statistical analysis
We investigated the power to detect marginal and epistatic genetic associations, assuming a 2-sided type 1 error of 5% (a ¼ 0.05). Results indicated that our investigation was well powered (80%) to detect allelic odds ratios of 0.8 and !1.2, respectively, and an epistatic ratio of odds ratios for interaction of 0.6 and !1.4, respectively, for almost all models considered (data not shown). Therefore, all analyses were performed and results interpreted in accordance with these established criteria. All subsequent statistical tests were 2-sided.
Allele frequencies between MS cases and controls were compared, and odds ratios, 95% confidence intervals, and significance criteria based on the Benjamini and Hochberg procedure for controlling the false discovery rate were determined by using PLINK v1.06 software (30) . The rs3135388 SNP, which is highly correlated with the HLA-DRB1*1501 allele (4), was also included; the presence or absence of the A variant was used to classify MS cases and controls for HLA-DRB1*1501 stratified analyses (*1501 carriers: 702 cases, 345 controls; *1501 noncarriers: 638 cases, 1,030 controls). Haplotype blocks were constructed by using D# confidence intervals (31) , and frequencies were compared by using Haploview v4.1 software (32). The conditional haplotype method was used to distinguish primary from secondary major histocompatibility complex associations. The conditional haplotype method tests for homogeneity of relative allele frequencies in cases and controls at a test locus on haplotypes identical for alleles at another locus (33) .
We tested all 2-way interactions between SNP variants within a single pathway by using unconditional logistic regression as implemented in PLINK (SNPs were coded as 0, 1, and 2, where 0 represents a homozygous genotype for the major allele). The test for epistasis was based on the coefficient of the interaction term (where the P value of the interaction term reflects the difference in the likelihood between the full model and a reduced model containing only main effects).
Furthermore, the potential biologic involvement of DNA repair pathways was explored by specifically investigating the combined effect of nonsynonymous SNPs (n ¼ 25) present in 18 genes (refer to Web Table 2 ), across all pathways. We hypothesized that the presence of multiple missense variants may contribute, additively, to MS risk. The combined effect of missense variants was determined by counting the total number of missense alleles for each individual. An appropriate reference group was determined by identifying the number of missense variants that reflected the lowest quartile ( 4 missense alleles (25.5% of the study population), similar to previous approaches (34, 35) ). Wilcoxon-type test for trend (36) and unconditional logistic regression analyses, adjusted for gender and HLA-DRB1*1501 (rs3135388) carrier status, were conducted by using STATA v9.2 software (Stata Corporation, College Station, Texas). The combined effect score was treated as both a categorical and continuous variable to determine the risk per strata and per allele.
Nonparametric methods were also used in parallel to univariate tests of association. Random Forests, a supervised machine learning algorithm that grows recursively partitioned trees without pruning (37) , and classification and regression trees (CART), a decision tree that presents a hierarchical arrangement of investigated variables, were utilized. Random Forests is essentially an extension of CART; however, it produces a collection of trees independently grown by using bootstrap aggregating and random selection of predictors to determine classification at each node. In the Random Forests algorithm, all predictors are considered simultaneously and the classification accuracy of the forest is assessed. Each predictor is randomly permuted across all trees, and changes in the classification accuracy (misclassification) are used to generate a variable importance score. The variable importance score can be used to rank predictors that contribute most to classifying the outcome in the context of all predictors without model specification and is fairly robust to uninformative predictors and outliers. Additionally, the variable importance score potentially includes the effect of multiplex interactions between the predictors because each variable selected at a node is essentially important conditional on the variable selected at the prior node, therefore incorporating additional information compared with univariate tests. To assist with the interpretation of important predictors identified by Random Forests, CART was used to explore and illustrate the conditional association(s) among these predictors.
For the Random Forests analyses, all genetic variants were coded as genotypes, and missing genotypes were imputed by using Beagle v2.1.3 software (38) . All genetic variants were used to predict MS disease status by using RandomForests v6.40.179 (http://salford-systems.com/) with mtry ¼ sqrt(p) and ntree ¼ 5,000. The analysis was repeated twice by excluding 1) HLA-DRB1*1501 (rs3135388) and 2) all chromosome 6p21 variants (rs3135388 and general transcription factor IIH, polypeptide 4 gene, GTF2H4, variants). Important (top-ranking) predictors from the Random Forests analysis were determined based on the distribution of the variable importance scores (refer to Web Figures 1-3 , which are also posted on the Journal's Web site (http://aje.oupjournals.org/)) and were chosen for further investigation by CART.
RESULTS
A total of 485 SNPs in 72 genes related to DNA repair pathways were investigated in 1,343 MS cases and 1,379 healthy controls of European ancestry. The rs3135388 A variant, which is highly correlated with HLA-DRB1*1501 (4) on chromosome 6p21.32, was significantly associated with MS risk, as expected (odds ratio ¼ 2.7, 95% confidence interval: 2.4, 3.1; P unadjusted <7.8 3 10
À48 ). Five SNPs demonstrated some evidence for an association with MS susceptibility; however, after adjusting for multiple testing, one significant association with MS susceptibility was observed (Table 1; refer to Web Table 3 
À5
). Interestingly, the GTF2H4 SNP (rs1264307) was not in linkage disequilibrium (r 2 < 0.01) with the HLA-DRB1*1501 tagging SNP (rs3135388). Similarly, HLA-DRB1*1501 stratified analyses did not reveal significant associations (Tables 2 and 3) , with the exception of GTF2H4, which was associated with decreased MS risk for *1501-negative individuals (odds ratio ¼ 0.74, P FDR-BH ¼ 0.03; Table 3 ). Haplotype analyses including 2 other GTF2H4 SNPs did not reveal additional information, demonstrating that the association was primarily due to rs1264307 (results not shown). Conditional haplotype method analysis of the HLA-DRB1*1501 tagging SNP (rs3135388) and the GTF2H4 variant (rs1264307) demonstrated that the HLA-DRB1*1501 allele conferred increased risk independent of GTH2H4 (Web Table 4 ).
A total of 31,666 epistatic interactions were investigated between SNPs within each specific pathway (6,780 base excision repair interactions, 15,911 nucleotide excision repair interactions, 5,659 homologous recombination interactions, and 3,316 nonhomologous end-joining interactions were formally tested); no interactions were significant after adjusting for multiple testing (results not shown). The multigenic investigation (combined effect) of the 25 nonsynonymous variants in 18 DNA repair genes did not demonstrate any association with MS susceptibility (P > 0.05; Web Table 5 ).
Chromosome 6p21 variants (HLA-DRB1*1501 and GTF2H4 (rs1264307)) were very important predictors of MS susceptibility from Random Forests analysis (refer to Web Figures 1 and 2 ). Because strong effects may mask the importance of other predictors, we removed, sequentially, HLA-DRB1*1501 data, followed by all chromosome 6p21 genotype data (HLA-DRB1*1501 and 3 GTF2H4 SNP variants), and we performed 2 additional random forests analyses. A total of 9 important predictors were additionally observed (refer to Web Figure 3 and Web Table 5 ). Seven of these predictors demonstrated P unadjusted < 0.05 when analyzed by using single locus association testing (Table 4) and included gene variants within 1) breast cancer 2 (BRCA2); 2) damage-specific DNA binding protein 2 (DDB2); 3) excision repair cross-complementing rodent repair deficiency, complementation group 3 (ERCC3); 4) RAD23 homolog A (RAD23A); 5) replication protein A3 (RPA3); 6) XPA binding protein 2 (XAB2); and 7) x-ray repair complementing defective repair in Chinese hamster cells 1 (XRCC4). Using CART, a classification tree including 5 of the 9 important predictors was constructed. The relation between these genetic variants is illustrated in Figure 1 . Interestingly, 4 variants were located within nucleotide excision repair genes. The top-ranking Random Forests SNP and the variant used in the first node of the classification tree was an intronic XAB2 variant (rs4134860; odds ratio ¼ 1.26, P unadjusted ¼ 9.7 3 10 À4 from single-locus testing).
DISCUSSION
DNA damage from both endogenous and exogenous sources continuously challenges the genomic integrity of both nuclear DNA and mitochondrial DNA. Fortunately, DNA repair processes help maintain genetic stability and play an important role in maintaining a healthy immune and nervous system (39, 40) . Over 150 genes are involved in the known nuclear DNA and mitochondrial DNA repair pathways. The current study focused on common genetic variation within 72 genes derived from 4 principal DNA repair pathways: base excision repair, nucleotide excision repair, homologous recombination, and nonhomologous end joining. We observed significant evidence for an association between an SNP in GTF2H4, a nucleotide excision repair gene, and MS risk. Significant results for other genetic variants based on marginal, epistatic, and multigenic tests of association were not observed after stringent correction for multiple testing.
Using a nonparametric approach comprising the Random Forests and CART algorithms, we observed evidence for a predictive relation for MS based on 9 variants in nucleotide excision repair, homologous recombination, and nonhomologous end-joining genes. Specifically, variants within nucleotide excision repair genes were most prominent among predictors of MS; that is, 4 of 5 variants incorporated Abbreviations: CI, confidence interval; DCLRE1C, DNA cross-link repair 1C; FDR-BH, false discovery rate (Benjamini and Hochberg); GTF2H4, general transcription factor IIH, polypeptide 4; HLA, human leukocyte antigen; MRE11A, meiotic recombination 11 homolog A; OR, odds ratio; POLE, polymerase (DNA directed), epsilon; RAD54L, RAD54-like homolog; SNP, single nucleotide polymorphism; XRCC1, x-ray repair complementing defective repair in Chinese hamster cells 1; XRCC2, x-ray repair complementing defective repair in Chinese hamster cells 2; XRCC4, x-ray repair complementing defective repair in Chinese hamster cells 4.
a Among 638 multiple sclerosis cases and 1,030 controls who did not carry the rs3135388 A risk variant. into the classification tree were in the XAB2, RPA3, ERCC3, and DDB2 genes. In general, nucleotide excision repair is responsible for removing nuclear DNA lesions distorting the DNA helix (i.e., bulky DNA adducts) through several steps, which include lesion detection, incision of the damaged strand, removal of the lesion-containing oligonucleotide, replacement of the removed oligonucleotide, and DNA ligation (41, 42) . The GTF2H4 rs1264307 SNP, located in intron 11, was significantly associated with MS susceptibility, and the association was predominantly found for *1501 noncarriers. GTF2H4 encodes an integral subunit (p52) of the important transcription factor IIH (TFIIH) protein complex, the helicase responsible for unwinding DNA structure, allowing repair (41) . The rs1264307 variant is less than 150 base pairs from exon 12 in GTF2H4 and is in strong linkage disequilibrium (r 2 ¼ 1) with several SNPs beyond exons 12 and 13 among Utah residents of northern and western European ancestry (exon 12 and 13 variants were not available in phased HapMap data for Utah residents of northern and western European ancestry from the HapMap project (26)). Additionally, SNP rs1264307 resides within a haplotype block spanning 38 kb and 3 other genes (valyl-tRNA synthetase 2 (VARS2), surfactant associated 2 (SFTA2), and diffuse panbronchiolotis critical region 1 (DPCR1)). An SNP (rs1264303) within the 5# UTR region of VARS2 and immediately centromeric to GTF2H4 was also in strong linkage disequilibrium (r 2 ¼ 1) with our variant among Utah residents of northern and western European ancestry and shows evidence for an association with MS risk (odds ratio ¼ 0.83, P ¼ 1.3 3 10 À3 ) in an independent data set (931 cases, 2,431 controls; data not shown) (4) .
GTF2H4 is located on chromosome 6p21.33, among several major histocompatibility complex class I genes; however, it was not in linkage disequilibrium (r 2 < 0.01) with HLA-DRB1*1501 (rs3135388) on chromosome 6p21.32.
Conditional haplotype analysis confirmed that HLA-DRB1*1501 conferred increased risk of MS, independent of GTF2H4 (Web Table 4 ). However, the potential involvement of HLA-class I genes (43) and the well-established allelic heterogeneity at the HLA-DRB1 locus in MS (44, 45) underscore the need to fully examine GTF2H4 and nearby variation in conjunction with full major histocompatibility complex data and classical HLA loci. Although HLA-DRB1*1501 status was established for all MS cases and controls in the current study, complete HLA-DRB1 typing was not available.
It was important to simultaneously consider genetic variation in these pathways because multigene variants have been associated with diminished DNA repair capacity and persistent DNA damage (46, 47) and, by extension, could influence apoptosis (48) and cellular senescence (49) . In the current study, we specifically investigated 25 nonsynonymous coding SNPs in 18 DNA repair genes. However, a combined effect of missense variants based on carrier status for number of alleles at each locus showed no evidence of association with MS.
We cannot exclude the potential role of other, yet unidentified environmental factors interacting with DNA repair genes to influence risk of MS. Interactions between DNA repair and exposure to tobacco smoke have been implicated in some cancers (50, 51) . Whether gene-environment associations are important in MS, given strong evidence for smoking as a risk factor (20, 21, (52) (53) (54) , needs further investigation. Moreover, although common genetic variants within DNA repair genes were genotyped and/or captured and subsequently were excluded as major risk factors for MS in the present study, risk due to rare variants, perhaps in particular subsets of MS cases, cannot be excluded.
The primary strengths of this pathway-driven candidate gene investigation in MS are 1) the availability of dense genotyping across defined candidate genes, allowing for a comprehensive investigation of 4 DNA repair pathways; 2) the use of a homogenous study population; 3) the use of a large study population that was statistically well powered to identify modest genetic effects; 4) the implementation of stringent significance criteria, allowing for clearer interpretation of results; 5) the application of a multigenic approach to investigate biologically functional variants from these pathways; and 6) the parallel application of nonparametric methods to complement marginal tests of association. Despite the strengths of this investigation, these results must be interpreted cautiously because a replication analysis was not conducted to confirm these reported associations, and no environmental exposures were available. Determining the biologic relevance of DNA repair pathways, particularly nucleotide excision repair, in MS will require more extensive genetic and molecular research.
